Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Human anti-PSCA CAR macrophages possess potent antitumor activity against pancreatic cancer

Cell stem cell(2024)10.1016/j.stem.2024.03.018Source: DataRank Database

Human anti-PSCA CAR macrophages possess potent antitumor activity against pancreatic cancer is a research paper published in Cell stem cell (2024). On theSindex it has a DataRank of 0. It has been cited 80 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access80 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (21 grants)Impact (FWCI 14.72)OA: greenTopics (40)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Lei Tian ORCID,Zhixin Li ORCID,Lewei Jin,Jianying Zhang ORCID,Zhenlong Li ORCID

Live enrichment

PubMed:38663406 PMC:PMC11162318 OpenAlex:https://openalex.org/W4395085149

California Institute for Regenerative Medicine

Grant: TRAN1-14003

California Institute for Regenerative Medicine

Grant: TRAN1-14716

California Institute for Regenerative Medicine

Grant: DISC2-14190

National Institutes of Health

Grant: CA265095

National Institutes of Health

Grant: CA247550

National Institutes of Health

Grant: CA163205

National Institutes of Health

Grant: CA223400

National Institutes of Health

Grant: CA266457

National Institutes of Health

Grant: NS106170

National Institutes of Health

Grant: CA210087

National Institutes of Health

Grant: AI129582

National Institutes of Health

Grant: CA264512

NCI NIH HHS

Grant: R01 CA265095

NCI NIH HHS

Grant: U19 CA264512

NCI NIH HHS

Grant: P01 CA163205

NCI NIH HHS

Grant: R01 CA247550

NCI NIH HHS

Grant: R01 CA266457

NCI NIH HHS

Grant: R35 CA210087

NIAID NIH HHS

Grant: R01 AI129582

NCI NIH HHS

Grant: R21 CA223400

NINDS NIH HHS

Grant: R01 NS106170

FWCI

14.72

Citation Percentile

1.0%

Influential Citations

Citation Trend

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11162318/pdf/nihms-1989149.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1934590924001243?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1934590924001243?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11162318

Fields of Study

CAR-T cell therapy researchPhagocytosis and Immune RegulationImmunotherapy and Immune ResponsesMedicine

MeSH Terms

Receptors, Chimeric AntigenAnimalsAntigens, NeoplasmHumansMacrophagesNeoplasm ProteinsPancreatic NeoplasmsImmunotherapy, AdoptiveMice, SCIDXenograft Model Antitumor AssaysCell Line, TumorMiceInduced Pluripotent Stem CellsGPI-Linked Proteins

Keywords

Chimeric antigen receptorCancer researchBiologyImmune systemPancreatic cancerImmunotherapyCytokineIn vivoInduced pluripotent stem cellProgenitor cellCancerImmunologyStem cellCell biologyEmbryonic stem cellMacrophagesSolid tumorProstate stem cell antigenCancer ImmunotherapyHuman Induced Pluripotent Stem CellsCytokine Release SyndromeOff-the-shelf

Sustainable Development Goals

SDG 0: Good health and well-being